The Motley Fool Discussion Boards

Previous Page

Investing/Strategies / Bonds & Fixed Income Investments


Subject:  Re: mead johnson nutrition 2019 Date:  11/26/2012  1:41 PM
Author:  trader2012 Number:  34526 of 35930


Though currently profitable, what is the target demographic for the company, and what are the birth-rate trends in those countries? Do you really expect that company to do well over the next 27 years? If so, why are the stock guys selling it down?

Mead Johnson's 5/9's of '39 are a non-callable, unsecured, triple-BBB, priced at 127, offering a mere 4% YTM. You ought to be ashamed of yourself for touting such a piece of trash.

Copyright 1996-2016 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us